Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2009-N-0302]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADAs) and an abbreviated new animal drug application (ANADA) listed in table 1 of this document. In a final rule published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is amending the animal drug regulations to remove portions reflecting approval of these NADAs and ANADA.
 DATES: Withdrawal of approval is effective August 3, 2009.
 FOR FURTHER INFORMATION CONTACT: John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, e-mail: 
                        *john.bartkowiak@fda.hhs.gov*.


SUPPLEMENTARY INFORMATION: The following sponsors have requested that FDA withdraw approval of the two NADAs and ANADA listed in table 1 of this document because the products are no longer manufactured or marketed: **Table 1.**
Sponsor
NADA/ANADA Number
                             Product (Drug)
21 CFR Cite Affected 
                             (Sponsor Drug Labeler Code)Wellmark International, 1501 East Woodfield Rd., suite 200, West Schaumburg, IL 60173
NADA 141-162
                             Zodiac Fleatrol Flea Caps (S-methoprene)
520.1390 (011536)IDEXX Pharmaceuticals, Inc., 7009 Albert Pick Rd., Greensboro, NC 27409
NADA 141-178
                             NAVIGATOR Paste (nitazoxanide)
520.1498 (065274)Abbott Laboratories, North Chicago, IL 60064
ANADA 200-279
                             KETAFLO Injection (ketamine HCl, USP)
522.1222a (000074)
 Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with § 514.116 
                    *Notice of withdrawal of approval of application*
                     (21 CFR 514.116), notice is given that approval of NADAs 141-162 and 141-178, and ANADA 200-279, and all supplements and amendments thereto, are hereby withdrawn, effective August 3, 2009. In a final rule published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs. Dated: July 14, 2009. Bernadette Dunham, Director, Center for Veterinary Medicine.


[FR Doc. E9-17408 Filed 7-21-09; 8:45 am] BILLING CODE 4160-01-S